-
Efficacy of Pregabalin and High-Concentration (179 mg) Capsaicin Patch in Peripheral Neuropathic Pain: A Review of Studies ≥ 26 Weeks' Duration
Sep 9, 2025, 16:22 PM -
What Makes a Medicine Innovative? A Literature Review of Evaluation Frameworks
Sep 9, 2025, 16:22 PM -
Utility Estimates for Health States Associated With Immune Thrombocytopenia: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Frameworks for the Use of AI Within HEOR: A Targeted Literature Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Multiplex Cell Culture Technology for Predicting Carboplatin Plus Paclitaxel-Induced Side Effects in Cancer Care
Sep 9, 2025, 16:22 PM -
Model Behavior: A Health Economics Checklist for Sales Models
Sep 9, 2025, 16:22 PM -
Unmet Needs in NICE HTAs: Insights From Obesity and Diabetes Submissions
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Estimated Long-Term Healthcare Cost Savings From EVP Use in the UK
Sep 9, 2025, 16:22 PM -
Comparing Clinical Benefit Criteria in Health Technology Assessment of Oncology Drugs in the Netherlands and Europe: Driving Real Value or Inequal Access?
Sep 9, 2025, 16:22 PM -
Reassessing NICE's Highly Specialized Technologies (HST) Criteria: A Retrospective Review of Borderline and Approved Appraisals Under the Revised Framework
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Personalized Lifestyle Interventions in Obesity/Overweight: A Systematic Review
Sep 9, 2025, 16:22 PM -
Evaluation of Real-World Data Landscape in the United Kingdom: A Scoping Review
Sep 9, 2025, 16:22 PM -
Using a Large Language Model (LLM) for Data Extraction of Studies: Learnings From a Targeted Literature Review (TLR) in Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Generalizability of Patient Preference Study Results: A Weight and Test Approach
Sep 9, 2025, 16:22 PM -
Faricimab vs. Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration: A Cost-Utility Analysis in Italy
Sep 9, 2025, 16:22 PM -
Psychometric Performance of EQ-HWB for Japanese Populations
Sep 9, 2025, 16:22 PM -
Lung-Cancer Diagnostic Trajectories: A Nationwide Process-Mining Cluster Analysis of 18,569 French Patients
Sep 9, 2025, 16:22 PM -
Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Subsequent Anticancer Therapy Use on Life-Year and QALY Estimates in Late-Line Metastatic Colorectal Cancer: A Health Economic Analysis of FRESCO-2
Sep 9, 2025, 16:22 PM
